Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGT ((VSE:IGT) Blockbuster Anti-Cancer Test Results !!! -- Ignore unavailable to you. Want to Upgrade?

To: Spiney who wrote (72)	11/5/1999 8:12:00 PM
From: m jensen	Respond to of 94

Well Spiney someone feels we are going places! IGT Pharma shares acquires by Peter Allard IGT Pharma Inc IGT Shares issued 8,819,820 Nov 4 close $0.62 Fri 5 Nov 99 News Release Mr. Peter Allard reports Peter Allard has acquired, pursuant to a private placement 857,142 units of IGT Pharma at a price of 70 cents per unit, a reporting issuer whose shares are listed and posted for trading on the Vancouver Stock Exchange. Each unit consists of one common share and one share purchase warrant. One and a half share purchase warrants will be equivalent to one warrant share. The private placement will be carried out in two tranches. The first tranche consists of 285,714 units and has been completed as of Nov. 4, 1999. The second tranche consists of 571,428 units and is subject to receipt of shareholder approval which is scheduled for the next shareholders special meeting to be held on Dec. 10, 1999. As a result of the acquisition of the first tranche, Mr. Allard, as of Nov. 4, 1999, had direct or indirect beneficial ownership over 1,530,614 common shares and 285,714 share purchase warrants, which if exercised would amount to 190,476 common shares of the company, representing approximately 17.3 per cent of the issued and outstanding share capital as at such date. Should shareholder approval be obtained, Mr. Allard would own 2,102,042 common shares and 957,142 share purchase warrants, which if exercised would represent 571,428 common shares of the company, representing approximately 24.5 per cent of the issued and outstanding share capital. Mr. Allard has purchased the securities for investment purposes. Mr. Allard may in the future increase his beneficial ownership of, or control or direction over, additional shares of the company depending on the circumstances. Mr. Allard, a lawyer by profession, is a businessman residing in Barbados.